About Bandaram Pharma Packtech Limited
Data last updated: 15 July 2026
Bandaram Pharma Packtech Limited is a public limited company based in Bangalore, Karnataka, India. It specialises in paper and packaging products, a part of the broader manufacturing sector. Incorporated on 05 August 1993, the company has been in operation for over 33 years.
Registered with ROC Bangalore under CIN L93090KA1993PLC159827. Listed on BSE: 524602.
Capital: an authorised share capital of ₹19 Cr and a paid-up capital of ₹17.97 Cr. It is led by directors including Bhandaram Sathyavathi and Bhandaram Premsai Reddy.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 601 5Th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008.
As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹62.92 Cr, a growth of 70.23% compared to the previous year. The net worth stands at ₹31.37 Cr (up 98.27% YoY). Total assets are valued at ₹75.86 Cr (up 94.93% YoY).
The company is associated with 2 brands - Shiva Medicare, Bandaram Pharma Packtech. As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹18.42 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivamedicare.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address601 5Th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008
-
IndustryManufacturing, Paper & Packaging Products
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Bandaram Pharma Packtech Limited
Bandaram Pharma Packtech Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L93090KA1993PLC159827, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L93090KA1993PLC159827 | Current |
| L93090TG1993PLC088165 | Previous |
| L93090DL1993PLC186295 | Previous |
| L93090TN1993PLC025563 | Previous |
| L93090AP1993PLC088165 | Previous |
Associated Brands with Bandaram Pharma Packtech Limited
Bandaram Pharma Packtech Limited operates two associated brands: Shiva Medicare and Bandaram Pharma Packtech. These brands represent Bandaram Pharma Packtech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of auto retractable safety syringe | shivamedicare.com | |
| Pharmaceutical packaging solutions are provided by Bandaram Pharma Packtech. | bandaram.com |
Competitors & Alternatives of Bandaram Pharma Packtech Limited
Brands and companies operating in the same space as Bandaram Pharma Packtech Limited include Legacy Pharma Solutions, Natural Capsules, SCHOTT Poonawalla and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Contract pharmaceutical packaging company | Earth City, United States, United States | 2003 |
|
|
Manufacturing and supply chain services for biopharma sector are provided. | Bengaluru, India, India | 1993 |
|
|
Packaging solutions for pharmaceutical and biotech industries are provided. | Mumbai, India, India | 1990 |
|
|
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms | Mumbai, India, India | 1999 |
|
|
Plastic packaging solutions for pharmaceutical products are manufactured. | Bensheim, Germany, Germany | 1894 |
|
|
Drugs for the biopharma sector are manufactured and supplied. | Pune, India, India | 2011 |
|
|
Provider of drugs packaging services | Hanover, United States, United States | 1999 |
|
|
Diabetes management and lifestyle modification services are provided. | Cambridge, United States, United States | 2010 |
Auditor Details of Bandaram Pharma Packtech Limited
Bandaram Pharma Packtech Limited is audited by M/s M.M Reddy & Co., (ICAI peer reviewed, certificate valid till 2028-03-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s M.M Reddy & Co., (ICAI peer reviewed, certificate valid till 2028-03-31) | FY 2026 | Statement on impact of audit qualification |
Board of Directors of Bandaram Pharma Packtech Limited
Bandaram Pharma Packtech Limited is currently managed by 7 directors, with 26 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Bhandaram Sathyavathi
Also directs:
Bandaram Pharma Packtech Limited
|
Director | 07 Mar 2022 | 4 Years 5 Months | Current |
| Bhandaram Premsai Reddy | Director | 07 Mar 2022 | 4 Years 5 Months | Current |
| Suryaprakasa Rao Bommisetti | Director | 07 Mar 2022 | 4 Years 5 Months | Current |
| Deepak Bandaram | Managing Director | 07 Feb 2023 | 3 Years 6 Months | Current |
|
Mounika Pammi
Also directs:
Bandaram Pharma Packtech Limited, Ratiorise Capital Advisory Llp, Midland Polymers Limited and 5 more
|
Director | 20 Jun 2025 | 1 Years 1 Months | Current |
|
Suman Mallu
Also directs:
Bandaram Pharma Packtech Limited, Vsr Paper And Packaging Limited
|
Director | 01 Sep 2023 | 2 Years 11 Months | Current |
Financials of Bandaram Pharma Packtech Limited FY 2026 filings available
Bandaram Pharma Packtech Limited reported revenue of ₹62.92 Cr (up 70.23% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹62.92 Cr | ₹36.96 Cr | ₹34.08 Cr | ₹18.73 Cr |
| Other Income | ₹1.8 Lakh | ₹9.4 Lakh | ₹3.31 Lakh | ₹19.03 Lakh |
| Total Income | ₹62.94 Cr | ₹37.06 Cr | ₹34.11 Cr | ₹18.92 Cr |
| Cost of Materials Consumed | ₹55.02 Cr | ₹30.96 Cr | ₹29.85 Cr | ₹16.05 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹1.17 Cr | -₹1.31 Cr | -₹2.54 Cr | ₹0 |
| Employee Benefit Expense | ₹3.91 Cr | ₹2.96 Cr | ₹2.33 Cr | ₹63.94 Lakh |
| Finance Costs | ₹1.51 Cr | ₹61.27 Lakh | ₹93.44 Lakh | ₹43.23 Lakh |
| Depreciation & Amortisation | ₹97.37 Lakh | ₹98.7 Lakh | ₹72.91 Lakh | ₹58.51 Lakh |
| Other Expenses | ₹2.26 Cr | ₹1.53 Cr | ₹1.63 Cr | ₹89.16 Lakh |
| Total Expenses | ₹62.5 Cr | ₹35.74 Cr | ₹32.93 Cr | ₹18.6 Cr |
| Profit Before Exceptional Items & Tax | ₹44.13 Lakh | ₹1.32 Cr | ₹1.19 Cr | ₹32.57 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹44.13 Lakh | ₹1.32 Cr | ₹1.19 Cr | ₹32.57 Lakh |
| Total Tax Expense | ₹15.98 Lakh | ₹32.22 Lakh | ₹21.88 Lakh | ₹6.81 Lakh |
| Net Profit | ₹28.15 Lakh | ₹99.38 Lakh | ₹96.78 Lakh | ₹25.76 Lakh |
| attributable to Owners | ₹54.66 Lakh | - | - | - |
| attributable to NCI | ₹44.72 Lakh | - | - | - |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹28.15 Lakh | ₹99.38 Lakh | ₹96.78 Lakh | ₹25.76 Lakh |
| EBITDA (computed) | ₹2.92 Cr | ₹2.92 Cr | ₹2.85 Cr | ₹1.34 Cr |
| Basic EPS | ₹0.83 | ₹0.83 | ₹0.81 | ₹0.47 |
| Diluted EPS | ₹0.83 | ₹0.83 | ₹0.81 | ₹0.47 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹75.86 Cr | ₹38.92 Cr | ₹32.06 Cr | ₹20.17 Cr |
| Non-current Assets | ₹18.87 Cr | ₹8.04 Cr | ₹5.99 Cr | ₹5.11 Cr |
| Current Assets | ₹56.99 Cr | ₹30.88 Cr | ₹26.06 Cr | ₹15.06 Cr |
| Property, Plant & Equipment | ₹9.41 Cr | ₹3.95 Cr | ₹4.48 Cr | ₹5.03 Cr |
| Inventories | ₹12.94 Cr | ₹8.51 Cr | ₹6.47 Cr | ₹2.71 Cr |
| Trade Receivables | ₹31.35 Cr | ₹18.76 Cr | ₹14.52 Cr | ₹6.62 Cr |
| Cash & Equivalents | ₹72.25 Lakh | ₹11.86 Lakh | ₹4.2 Lakh | ₹15.69 Lakh |
| Equity (Net Worth) | ₹31.37 Cr | ₹15.82 Cr | ₹15.07 Cr | ₹5.13 Cr |
| Equity Share Capital | ₹17.97 Cr | ₹12 Cr | ₹12 Cr | ₹3 Cr |
| Borrowings (Non-current) | ₹10.05 Cr | ₹8.99 Cr | ₹4.68 Cr | ₹7.65 Cr |
| Borrowings (Current) | ₹13.89 Cr | ₹8.16 Cr | ₹7.53 Cr | ₹6.56 Cr |
| Total Debt (computed) | ₹23.95 Cr | ₹17.15 Cr | ₹12.2 Cr | ₹14.2 Cr |
| Current Liabilities | ₹34.33 Cr | ₹14.03 Cr | ₹12.24 Cr | ₹7.35 Cr |
| Total Liabilities | ₹44.5 Cr | ₹23.1 Cr | ₹16.99 Cr | ₹15.04 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | -₹4.92 Cr | -₹4.93 Cr | -₹4.13 Cr | -₹1.1 Cr |
| Investing Cash Flow | ₹0 | -₹7.89 Lakh | -₹1.58 Cr | -₹5.3 Cr |
| Financing Cash Flow | ₹5.53 Cr | ₹5.09 Cr | ₹5.59 Cr | ₹4.47 Cr |
| Capital Expenditure | ₹0 | ₹7.89 Lakh | ₹17.91 Lakh | ₹0 |
| Free Cash Flow (computed) | -₹4.92 Cr | -₹5.01 Cr | -₹4.31 Cr | -₹1.1 Cr |
| Dividends Paid | ₹0 | ₹12 Lakh | ₹0 | ₹0 |
| Net Change in Cash | ₹60.4 Lakh | ₹7.66 Lakh | -₹11.48 Lakh | -₹1.93 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹26.26 Cr | ₹14.84 Cr | ₹13.72 Cr | ₹8.1 Cr | ₹8.49 Cr | ₹10 Cr | ₹7.11 Cr | ₹11.37 Cr |
| Other Income | ₹97,000 | ₹0 | ₹83,000 | ₹0 | ₹9.4 Lakh | ₹0 | ₹0 | ₹0 |
| Total Income | ₹26.27 Cr | ₹14.84 Cr | ₹13.73 Cr | ₹8.1 Cr | ₹8.59 Cr | ₹10 Cr | ₹7.11 Cr | ₹11.37 Cr |
| Cost of Materials Consumed | ₹23.13 Cr | ₹14.02 Cr | ₹10.89 Cr | ₹6.48 Cr | ₹4.38 Cr | ₹8.12 Cr | ₹5.17 Cr | ₹13.29 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹1.1 Cr | -₹1.44 Cr | ₹1.43 Cr | -₹6.17 Lakh | ₹2.16 Cr | ₹26.1 Lakh | -₹24.62 Lakh | -₹3.49 Cr |
| Employee Benefit Expense | ₹2.25 Cr | ₹57.66 Lakh | ₹52.92 Lakh | ₹54.6 Lakh | ₹1.08 Cr | ₹59.53 Lakh | ₹69.23 Lakh | ₹58.55 Lakh |
| Finance Costs | ₹45.9 Lakh | ₹33.45 Lakh | ₹25.2 Lakh | ₹46.02 Lakh | -₹9.93 Lakh | ₹23.94 Lakh | ₹26 Lakh | ₹21.26 Lakh |
| Depreciation & Amortisation | ₹24.87 Lakh | ₹13.53 Lakh | ₹13.62 Lakh | ₹13.44 Lakh | ₹53.16 Lakh | ₹15.18 Lakh | ₹15.36 Lakh | ₹15 Lakh |
| Other Expenses | ₹1.14 Cr | ₹67.31 Lakh | ₹42.51 Lakh | ₹50.56 Lakh | ₹32.14 Lakh | ₹36.37 Lakh | ₹40.59 Lakh | ₹44.35 Lakh |
| Total Expenses | ₹26.13 Cr | ₹14.31 Cr | ₹13.66 Cr | ₹8.07 Cr | ₹8.38 Cr | ₹9.73 Cr | ₹6.44 Cr | ₹11.19 Cr |
| Profit Before Exceptional Items & Tax | ₹13.7 Lakh | ₹53 Lakh | ₹7.76 Lakh | ₹3.55 Lakh | ₹20.03 Lakh | ₹26.55 Lakh | ₹67.19 Lakh | ₹17.83 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹13.7 Lakh | ₹53 Lakh | ₹7.76 Lakh | ₹3.55 Lakh | ₹20.03 Lakh | ₹26.55 Lakh | ₹67.19 Lakh | ₹17.83 Lakh |
| Total Tax Expense | ₹3.06 Lakh | ₹18.06 Lakh | ₹1.74 Lakh | ₹1.08 Lakh | ₹4.33 Lakh | ₹27.89 Lakh | ₹0 | ₹0 |
| Net Profit | ₹10.64 Lakh | ₹34.94 Lakh | ₹6.02 Lakh | ₹2.47 Lakh | ₹15.7 Lakh | -₹1.34 Lakh | ₹67.19 Lakh | ₹17.83 Lakh |
| attributable to Owners | -₹44.37 Lakh | ₹0 | ₹0 | ₹1.36 Lakh | - | -₹74,000 | - | - |
| attributable to NCI | ₹72.95 Lakh | ₹0 | ₹0 | ₹1.11 Lakh | - | -₹60,000 | - | - |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹10.64 Lakh | ₹34.94 Lakh | ₹6.02 Lakh | ₹2.47 Lakh | ₹15.7 Lakh | -₹1.34 Lakh | ₹67.19 Lakh | ₹17.83 Lakh |
| EBITDA (computed) | ₹84.47 Lakh | ₹99.98 Lakh | ₹46.58 Lakh | ₹63.01 Lakh | ₹63.26 Lakh | ₹65.67 Lakh | ₹1.09 Cr | ₹54.09 Lakh |
| Basic EPS | ₹0.06 | ₹0.11 | ₹0.03 | ₹0.01 | ₹0.13 | ₹-0.01 | ₹0.56 | ₹0.15 |
| Diluted EPS | ₹0.06 | ₹0.11 | ₹0.03 | ₹0.01 | ₹0.13 | ₹-0.01 | ₹0.56 | ₹0.15 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹10.96 Cr | ₹12.23 Cr | ₹14.84 Cr | ₹10.09 Cr | ₹0 |
| Other Income | ₹83,000 | ₹9.39 Lakh | ₹2.68 Lakh | ₹0 | ₹0 |
| Total Income | ₹10.97 Cr | ₹12.32 Cr | ₹14.87 Cr | ₹10.09 Cr | ₹0 |
| Cost of Materials Consumed | ₹10.6 Cr | ₹10.44 Cr | ₹12.89 Cr | ₹9.33 Cr | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹87.75 Lakh | ₹1.1 Cr | ₹1.14 Cr | ₹7.71 Lakh | ₹0 |
| Finance Costs | ₹3,000 | ₹2,000 | ₹1,000 | ₹5,000 | ₹1,000 |
| Depreciation & Amortisation | ₹21,000 | ₹56,000 | ₹1.54 Lakh | ₹17,000 | ₹0 |
| Other Expenses | ₹64.42 Lakh | ₹59.49 Lakh | ₹65.13 Lakh | ₹40.93 Lakh | ₹1 Lakh |
| Total Expenses | ₹12.13 Cr | ₹12.14 Cr | ₹14.69 Cr | ₹9.82 Cr | ₹1.01 Lakh |
| Profit Before Exceptional Items & Tax | -₹1.16 Cr | ₹18.52 Lakh | ₹17.12 Lakh | ₹27.22 Lakh | -₹1.01 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹1.16 Cr | ₹18.52 Lakh | ₹17.12 Lakh | ₹27.22 Lakh | -₹1.01 Lakh |
| Total Tax Expense | -₹11,000 | ₹4.52 Lakh | ₹4.28 Lakh | ₹6.8 Lakh | ₹0 |
| Net Profit | -₹1.16 Cr | ₹14 Lakh | ₹12.84 Lakh | ₹20.42 Lakh | -₹1.01 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹1.16 Cr | ₹14 Lakh | ₹12.84 Lakh | ₹20.42 Lakh | -₹1.01 Lakh |
| EBITDA (computed) | -₹1.16 Cr | ₹19.1 Lakh | ₹18.67 Lakh | ₹27.44 Lakh | -₹1 Lakh |
| Basic EPS | ₹-0.64 | ₹0.12 | ₹0.11 | ₹0.68 | ₹0.00 |
| Diluted EPS | ₹-0.64 | ₹0.12 | ₹0.11 | ₹0.68 | ₹0.00 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | ₹36.61 Cr | ₹19.21 Cr | ₹13.36 Cr | ₹8.27 Cr | ₹3 Cr |
| Non-current Assets | ₹21.39 Cr | ₹6.59 Cr | ₹3.92 Cr | ₹2.53 Cr | ₹91.66 Lakh |
| Current Assets | ₹15.21 Cr | ₹12.62 Cr | ₹9.43 Cr | ₹5.74 Cr | ₹2.08 Cr |
| Property, Plant & Equipment | ₹12,000 | ₹33,000 | ₹90,000 | ₹2.43 Lakh | ₹0 |
| Inventories | ₹2.08 Cr | ₹1.64 Cr | ₹2.16 Cr | ₹54.98 Lakh | ₹0 |
| Trade Receivables | ₹10.67 Cr | ₹6.62 Cr | ₹2.9 Cr | ₹2.69 Cr | ₹0 |
| Cash & Equivalents | ₹25.95 Lakh | ₹1.76 Lakh | ₹4.04 Lakh | ₹8.53 Lakh | ₹2.08 Cr |
| Equity (Net Worth) | ₹22.89 Cr | ₹12.1 Cr | ₹12.21 Cr | ₹3.07 Cr | ₹2.99 Cr |
| Equity Share Capital | ₹17.97 Cr | ₹12 Cr | ₹12 Cr | ₹3 Cr | ₹3 Cr |
| Borrowings (Non-current) | ₹4.51 Cr | ₹3.49 Cr | ₹1.75 Lakh | ₹4.41 Cr | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹4.51 Cr | ₹3.49 Cr | ₹1.75 Lakh | ₹4.41 Cr | ₹0 |
| Current Liabilities | ₹9.21 Cr | ₹3.62 Cr | ₹1.13 Cr | ₹23.56 Lakh | ₹1 Lakh |
| Total Liabilities | ₹13.72 Cr | ₹7.11 Cr | ₹1.15 Cr | ₹5.19 Cr | ₹1 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹1.21 Cr | -₹3.25 Cr | -₹3.26 Cr | -₹3.87 Cr | -₹1.45 Cr |
| Investing Cash Flow | -₹2 Cr | ₹0 | -₹1.4 Cr | -₹2.53 Cr | -₹2.03 Cr |
| Financing Cash Flow | ₹1.03 Cr | ₹3.23 Cr | ₹4.61 Cr | ₹4.4 Cr | ₹5.56 Cr |
| Capital Expenditure | ₹2 Cr | ₹0 | ₹0 | ₹2.6 Lakh | ₹0 |
| Free Cash Flow (computed) | -₹78.66 Lakh | -₹3.25 Cr | -₹3.26 Cr | -₹3.89 Cr | -₹1.45 Cr |
| Dividends Paid | ₹0 | ₹12 Lakh | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹24.2 Lakh | -₹2.28 Lakh | -₹4.48 Lakh | -₹2 Cr | ₹2.08 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹8.2 Cr | ₹1.68 Cr | ₹32.93 Lakh | ₹75.74 Lakh | ₹3.71 Cr | ₹2.63 Cr | ₹3.17 Cr | ₹2.72 Cr |
| Other Income | ₹0 | ₹0 | ₹83,000 | ₹0 | ₹9.39 Lakh | ₹0 | ₹0 | ₹0 |
| Total Income | ₹8.2 Cr | ₹1.68 Cr | ₹33.76 Lakh | ₹75.74 Lakh | ₹3.8 Cr | ₹2.63 Cr | ₹3.17 Cr | ₹2.72 Cr |
| Cost of Materials Consumed | ₹7.86 Cr | ₹1.66 Cr | ₹32.92 Lakh | ₹79.79 Lakh | ₹3.11 Cr | ₹2.38 Cr | ₹2.26 Cr | ₹2.69 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | -₹4.4 Lakh | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹54.63 Lakh | ₹11.41 Lakh | ₹10.97 Lakh | ₹10.74 Lakh | ₹45.25 Lakh | ₹16.44 Lakh | ₹30.68 Lakh | ₹17.37 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹3,000 | ₹0 | ₹2,000 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹5,000 | ₹5,000 | ₹6,000 | ₹5,000 | ₹2,000 | ₹18,000 | ₹28,000 | ₹8,000 |
| Other Expenses | ₹12.47 Lakh | ₹11.02 Lakh | ₹24.52 Lakh | ₹16.41 Lakh | ₹18.49 Lakh | ₹4.02 Lakh | ₹26.54 Lakh | ₹10.44 Lakh |
| Total Expenses | ₹8.53 Cr | ₹1.89 Cr | ₹68.5 Lakh | ₹1.03 Cr | ₹3.75 Cr | ₹2.58 Cr | ₹2.84 Cr | ₹2.97 Cr |
| Profit Before Exceptional Items & Tax | -₹33.29 Lakh | -₹21.14 Lakh | -₹34.74 Lakh | -₹26.85 Lakh | ₹5.61 Lakh | ₹4.69 Lakh | ₹33.08 Lakh | -₹24.86 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹33.29 Lakh | -₹21.14 Lakh | -₹34.74 Lakh | -₹26.85 Lakh | ₹5.61 Lakh | ₹4.69 Lakh | ₹33.08 Lakh | -₹24.86 Lakh |
| Total Tax Expense | -₹11,000 | ₹0 | ₹0 | ₹0 | ₹1.3 Lakh | ₹3.22 Lakh | ₹0 | ₹0 |
| Net Profit | -₹33.18 Lakh | -₹21.14 Lakh | -₹34.74 Lakh | -₹26.85 Lakh | ₹4.31 Lakh | ₹1.47 Lakh | ₹33.08 Lakh | -₹24.86 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹33.18 Lakh | -₹21.14 Lakh | -₹34.74 Lakh | -₹26.85 Lakh | ₹4.31 Lakh | ₹1.47 Lakh | ₹33.08 Lakh | -₹24.86 Lakh |
| EBITDA (computed) | -₹33.24 Lakh | -₹21.09 Lakh | -₹34.65 Lakh | -₹26.8 Lakh | ₹5.65 Lakh | ₹4.87 Lakh | ₹33.36 Lakh | -₹24.78 Lakh |
| Basic EPS | ₹-0.18 | ₹-0.12 | ₹-0.29 | ₹-0.22 | ₹0.04 | ₹0.01 | ₹0.28 | ₹-0.21 |
| Diluted EPS | ₹-0.18 | ₹-0.12 | ₹-0.29 | ₹-0.22 | ₹0.04 | ₹0.01 | ₹0.28 | ₹-0.21 |
Shareholding Pattern of Bandaram Pharma Packtech Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 62.66%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 37.33% of Bandaram Pharma Packtech Limited. The company had 5,078 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 62.66% | 62.62% | 75.00% | 75.00% | 75.00% | 75.00% |
| Public | 37.34% | 37.38% | 25.00% | 25.00% | 25.00% | 25.00% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 62.66% | 75.00% | 75.00% |
| Public | 37.34% | 25.00% | 25.00% |
| Promoter change (YoY, %pts) | -12.34 | +0.00 | - |
Charges & Borrowings of Bandaram Pharma Packtech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 1992 | State Bank of India; | ₹25 Lakh | Open |
| 30 May 1992 | State Bank of India; | ₹25 Lakh | Open |
| 18 Jan 2024 | Others | ₹10 Cr | Satisfied |
| 16 Jun 1998 | State Bank of India; | ₹7 Cr | Satisfied |
| 30 Apr 1996 | Union Bank of India | ₹1.42 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Bandaram Pharma Packtech Limited
View historical data on people associated with Bandaram Pharma Packtech Limited, including employment history and EPFO contributions.
Employee and EPFO history for Bandaram Pharma Packtech Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Bandaram Pharma Packtech Limited
GST registrations and filing compliance for Bandaram Pharma Packtech Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Bandaram Pharma Packtech Limited
Credit ratings, litigation, and regulatory alerts for Bandaram Pharma Packtech Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bandaram Pharma Packtech Limited
MSME payment history for Bandaram Pharma Packtech Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bandaram Pharma Packtech Limited
Corporate group structure for Bandaram Pharma Packtech Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bandaram Pharma Packtech Limited
MCA filings and documents for Bandaram Pharma Packtech Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Bandaram Pharma Packtech Limited
Frequently Asked Questions about Bandaram Pharma Packtech Limited
Bandaram Pharma Packtech Limited is an active public limited company in the manufacturing sector based in Bangalore, Karnataka, India. It was incorporated on 05 August 1993 (33+ years old) and is registered under CIN L93090KA1993PLC159827. Listed on BSE: 524602.
Bandaram Pharma Packtech Limited reported revenue of ₹62.92 Cr for FY 2026 (up 70.23% YoY) based on consolidated BSE filings.
The current directors of Bandaram Pharma Packtech Limited are:
- Bhandaram Sathyavathi - Director
- Bhandaram Premsai Reddy - Director
- Suryaprakasa Rao Bommisetti - Director
- Deepak Bandaram - Managing Director
- Mounika Pammi - Director
- Suman Mallu - Director
- Eswar Reddy Putturu - Director
The primary industry of Bandaram Pharma Packtech Limited is manufacturing. The company specifically operates in paper and packaging products. The company is currently active in this sector.
Yes. Bandaram Pharma Packtech Limited is listed on BSE with code 524602.
Bandaram Pharma Packtech Limited can be reached at the registered office: 601 5Th Floor Oxford Towers Opp To Leela Palace Hotel Old Airport Road Kodihalli, Bangalore, Karnataka, India – 560008, or through the website shivamedicare.com.